Home
>
National Drug Code (NDC)
>
Clorazepate Dipotassium
Clorazepate Dipotassium - 43063-350-12 - (clorazepate dipotassium)
Drug Information of Clorazepate Dipotassium
| Product NDC: | 43063-350 |
| Proprietary Name: | Clorazepate Dipotassium |
| Non Proprietary Name: | clorazepate dipotassium |
| Active Ingredient(s): | 7.5 mg/1 & nbsp; clorazepate dipotassium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Clorazepate Dipotassium
| Product NDC: | 43063-350 |
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA071858 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100729 |
Package Information of Clorazepate Dipotassium
| Package NDC: | 43063-350-12 |
| Package Description: | 12 TABLET in 1 BOTTLE, PLASTIC (43063-350-12) |
NDC Information of Clorazepate Dipotassium
| NDC Code | 43063-350-12 |
| Proprietary Name | Clorazepate Dipotassium |
| Package Description | 12 TABLET in 1 BOTTLE, PLASTIC (43063-350-12) |
| Product NDC | 43063-350 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | clorazepate dipotassium |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100729 |
| Marketing Category Name | ANDA |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | CLORAZEPATE DIPOTASSIUM |
| Strength Number | 7.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |
